CA
NZ
UK
AU
IND
US
Why is WCT stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. The sharp decline likely reflects concerns about competitive pressures in China's digital health market and questions about profitability. Regulatory uncertainty in China's …
Why is RDNT stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. Healthcare reimbursement pressures affecting imaging center profitability. Concerns about utilization rates and pricing power. For investors tracking this name, understanding the catalysts …
Shares of Neogen Corporation (NASDAQ: NEOG) experienced a notable pullback on March 7, 2026, with the stock price dropping 9.3% to close at $9.70. The move caught the attention of both retail and institutional investors, as the company joined a broader wave of selling …
Why is LIXT stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. Clinical trial challenges or slow enrollment. Broader biotech funding pressures and early-stage valuation declines. For investors tracking this name, understanding the catalysts …
Why is DRTS stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. The decline may reflect concerns about clinical development progress, funding challenges, or competitive developments. Valuation or technical hurdles in advancing alpha radiation …
Why is ECOR stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. Slow adoption of vagus nerve stimulation therapy for migraines and other conditions. Insurance coverage uncertainty affects patient access. For investors tracking this …
Vir Biotechnology (NASDAQ:VIR) announced quarterlyearningsof (USD 0.31) per share. In the same quarter last year, the company reportedearningsof (USD 0.76) per share.
Telix Pharmaceuticals (NASDAQ:TLX) reported quarterlyearnings per shareof USD -0.01, compared with market expectations of USD 0.05, representing a shortfall of USD 0.06. Quarterly revenue came in at USD 413.4M, below the consensus estimate of USD 421.5M.
Bausch Health Cos Inc (NYSE:BHC) released its Q4earnings, reporting USD 1.08 per share, below the consensus estimate of USD 1.22 by USD 0.14, according to Zacks. The company recorded a net margin of 3.61%, whilereturn on equityshowed a striking negative figure of ‑9,620.34%, highlighting …
Shares of HCW Biologics Inc. (NASDAQ:HCWB) closed at USD 0.60 on February 18, down USD 0.049 or 7.54% for the session. The decline followed the company’s announcement of a USD 1.5 million follow-on offering priced at-the-market under Nasdaq rules. The pricing of the new …
Please wait processing your request...